The COVID19 binds to the ACE2 receptor in human cells via a spike protein and begins infection. S protein is used as a vaccine antigen that has already been developed.

We developed the spike protein in May 2020. In October 2020, the “COVID 19 antibody test service” that uses our spike proteins was released by a joint development partner. Furthermore, research and development for vaccine is currently under-development.

Our developed spike protein is sold as a reagent. Please contact us for prices and the other condistions individually.